Belatacept's Renal Transplant Benefits Persist Long-Term Renal and Urology News Graft loss occurred in none of the belatacept recipients and in three of the CsA recipients, two from acute rejection and one from chronic allograft nephropathy. The mean calculated glomerular filtration rate (mL/min/1.73 m2) using the Modification of ... |
